- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Max Healthcare raises Rs 1,200 crore via QIP issue route
New Delhi: Max Healthcare Institute Ltd (MHC) on Wednesday said it has raised Rs 1,200 crore via issue of securities. The company, which is the country's second largest private hospital chain, has raised the capital through qualified institutional placement (QIP).
The QIP opened on March 4, 2021, and closed on March 9, 2021.
The healthcare major has accordingly issued 6,14,12,482 fresh equity shares of face value of Rs 10 per share at a price of Rs 195.40 per share, MHC said in a statement.
Post the QIP, the issued and subscribed equity share capital of MHC stands at 96,59,45,006 equity shares, it added.
MHC proposes to utilise the net proceeds for meeting the capital expenditure and working capital requirements, including expansion of capacity, increasing stake in existing/future subsidiaries etc, it said.
The company may also use part of the proceeds for repayment of debt and for general corporate requirements or any other purposes as maybe permissible, it added.
"We would like to thank investors for their overwhelming response towards our QIP. With this, we have fortified our balance sheet to tap growth opportunities and also strengthened our investor base with blue chip domestic mutual funds and global long only funds," Max Healthcare Chairman and Managing Director Abhay Soi said.
MHC will continue to provide high-end medical care for patients by investing in cutting-edge clinical technologies, infrastructure, clinical and management talent, he added.
Pursuant to this issue, the public shareholding of MHC stands at 29.54 per cent.
However, this includes 4.82 per cent which is not currently considered for compliance towards minimum public shareholding threshold under Sebi regulations for listed companies.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story